Oculis Holding AG

General ticker "OCS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $762.2M (TTM average)

Oculis Holding AG follows the US Stock Market performance with the rate: 22.1%.

Estimated limits based on current volatility of 2.2%: low 20.41$, high 21.32$

Factors to consider:

  • Total employees count: 28 as of 2022
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [9.47$, 22.45$]
  • 2025-12-31 to 2026-12-31 estimated range: [6.75$, 16.78$]

Financial Metrics affecting the OCS estimates:

  • Negative: with PPE of -7.4 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -7.68 <= 0.33
  • Negative: negative Net income
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: 41.86 < Shareholder equity ratio, % of 60.97 <= 63.39
  • Negative: negative Industry operating cash flow (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term OCS quotes

Long-term OCS plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue CHF0.00MM CHF0.00MM CHF0.69MM
Operating Expenses CHF32.38MM CHF80.71MM CHF73.89MM
Operating Income CHF-32.38MM CHF-80.71MM CHF-73.20MM
Non-Operating Income CHF-6.27MM CHF-7.98MM CHF-12.73MM
Interest Expense CHF6.44MM CHF1.46MM CHF0.00MM
R&D Expense CHF22.22MM CHF29.25MM CHF52.08MM
Income(Loss) CHF-38.64MM CHF-88.69MM CHF-85.94MM
Profit(Loss)* CHF-38.70MM CHF-88.80MM CHF-85.78MM
Stockholders Equity CHF-97.99MM CHF93.73MM CHF73.38MM
Assets CHF37.06MM CHF114.35MM CHF120.35MM
Operating Cash Flow CHF-25.07MM CHF-53.84MM CHF-47.50MM
Capital expenditure CHF3.55MM CHF0.05MM CHF0.23MM
Investing Cash Flow CHF-3.55MM CHF-54.21MM CHF-17.56MM
Financing Cash Flow CHF1.71MM CHF129.67MM CHF54.03MM
Earnings Per Share** CHF-1.18 CHF-2.97 CHF-2.12

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.